Compare Sana Biotechnology Inc (SANA) vs Xpeng Inc - ADR (XPEV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sana Biotechnology Inc vs Xpeng Inc - ADR — how do they compare? Sana Biotechnology Inc trades at $3.17 (market cap $873.84M), while Xpeng Inc - ADR trades at $13.38 (market cap $12.96B). The key difference: Xpeng Inc - ADR is far larger — about 14.8× Sana Biotechnology Inc's market cap. Which is the better fit depends on your goals.
| SANA | XPEV | |
|---|---|---|
Market Cap | $873.84M | $12.96B |
Sector | Health | Consumer Cyclical |
52-Week High | $5.92 | $28.07 |
52-Week Low | $2.68 | $12.09 |
Enterprise Value | $848.03M | $15.07B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →About Xpeng Inc - ADR
Founded in 2015, XPeng is a leading Chinese smart electric vehicle, or EV, company that designs, develops, manufactures and markets EVs in China. Its products primarily target the growing base of technology-savvy middle-class consumers in the midrange to high-end segment in China's passenger vehicle market. The company sold over 98,000 EVs in 2021, accounting for about 3% of China's passenger new energy vehicle market. It is also a leader in autonomous driving technology.
Read more on XPEV →
